Progenicare

Progenicare is a regenerative medicine company that specializes in the development and distribution of point-of-care autologous cell therapy products and orthopedic biologics. The company's portfolio includes systems for concentrating bone marrow aspirate and platelet-rich plasma, as well as advanced bone grafting materials like the Progeni-Fuse demineralized bone matrix. Progenicare primarily serves the orthopedic and spine surgery markets, providing clinicians with tools to enhance healing and tissue regeneration. In 2016, the company was acquired by MiMedx Group to strengthen its presence in the surgical biologics sector and expand its distribution network.